Human Immunodeficiency Virus Therapeutics Market - Current Scenario and Forecast 2017 - 2025Therapeutics Market: Snapshot
With the noticeable surge in the incidence rate of human immunodeficiency virus (HIV)-1 infection, the market for HIV therapeutics market is gaining remarkable momentum across the world. The rate of demise from HIV-1 infection, however, is much higher than its occurrence rate. The number of people coming in contact with HIV is increasing at a fast pace, with emerging and under developed economies being severely hit as they lack adequate treatment facilities and prevention measures.
Hitherto, no cure to HIV infections has been discovered. However, with appropriate medical intervention and therapeutics, their severity on infected humans can be controlled, providing new life lease to patients. Entry and fusion inhibitors, NRTIs, Non-NRTIs, integrase inhibitors, coreceptor antagonists, and protease inhibitors are the main drug classes of the therapeutics for HIV. With a large number of anti-retro viral drugs, the NRTIs segment has emerged as the most prominent drug class in human immunodeficiency virus therapeutics.
Request Sample Copy of the Report @ www.tmrresearch.com/sample/sample?flag=B&rep_id=1187
NRTIs slow down reverse transcriptase activities and eventually apprehend viral replication, which helps in reducing the effects of the infection on the human body. In general, the anti-retroviral regimen, used for the treatment of HIV patients, has a combination of anti-retroviral agents from diverse drug classes. Currently, over twenty FDA-approved drugs for the treatment of HIV are commercially available across the world.
Global Human Immunodeficiency Virus Therapeutics Market: Overview
AIDS is perhaps the greatest threat posed by infectious diseases to human health in history. As this disease remains incurable at the moment, the development of anti- HIV therapies is crucial to slow down the progression of the virus. Therefore, the global market for HIV therapeutics will witness tremendous growth during the forthcoming period.
Almost 36.7 million people were suffering from this deadly disease towards the end of 2015, according to the findings of World Health Organization (WHO). As the incidence of AIDS is not likely to reduce anytime soon, the global HIV therapeutics market is expected to exhibit a positive trajectory in the forthcoming years.
Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=1187
The report by Transparency Market Research (TMR) discusses the trends, catalysts, opportunities, and deterrents of the global human immunodeficiency virus therapeutics market. The major vendors are studies in-depth, wherein their key business strategies, market shares, and product portfolios have been discussed. The market attractiveness, competitive landscape, market projections, supply and demand dynamics, and value chain analysis have also been revealed along with relevant statistical data.
Global Human Immunodeficiency Virus Therapeutics Market: Drivers and Restraints
The increasing prevalence of HIV infections, particularly amongst the youth worldwide owing to unprotected sexual activities, lack of awareness about the risk of transmission, and the usage of contaminated needles and syringes have been the most prominent growth drivers boosting the global HIV therapeutics market. The growing healthcare expenditures of governments and the gradual spread of awareness about the availability of anti-HIV therapies are also contributing towards market growth.
Research conducted in novel scientific arenas such as pharmacogenetics and pharmacogenomics have been backing up the expansion of the market. The most awaited advent of personalized treatments wherein medications are optimized for every single patient considering the individual's genetic makeup has raised the hopes of HIV positive patients. Several community groups, national research groups, regulatory bodies, pharmaceutical companies and patients have joined forces against HIV, working towards the development of effective HIV therapies. All this has triggered the growth of the global HIV therapeutics market. Moreover, as several drugs are constantly being developed and are entering clinical investigation each day, it is likely that they will be easily available in near future, promoting the expansion of the market substantially.
Get Discount @ www.tmrresearch.com/sample/sample?flag=D&rep_id=1187
Global Human Immunodeficiency Virus Therapeutics Market: Regional Outlook
On the basis of geography, the global human immunodeficiency virus therapeutics market can be segmented into Latin America, Europe, Asia Pacific, the Middle East and Africa, and North America.
Escalating incidence of this infection has been observed in Russia, Latin America, and several parts of Caribbean. Therefore, these regions are expected to display considerable demand over the coming period. The continents of Asia and Africa are plagued by this viral infection, with countries such as China, India, and Nigeria with high incidence of HIV infections. According to the WHO, 1 out of 25 people are suffering from HIV infection in the Sub-Saharan Africa, making up almost 70% of the entire global HIV population.
Steps taken by governments to improve access to HIV therapies in these emerging economies are likely to boost the demand for HIV therapeutics in these regions. Moreover, numerous national and international initiatives across the globe by institutions such as the HIVNAT (The Netherlands, Australia, and Thailand) Network, Harvard AIDS Institute, and MSF (Médecins Sans Frontières) have also been guiding growth.
Companies Mentioned in the Report
Some of the major companies operating in the global human immunodeficiency virus therapeutics market are ViiV Healthcare, Boehringer Ingelheim GmbH, Merck & Co., Cipla, Inc., Bristol-Myers Squibb Company, and AbbVie, Inc.
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.
3739 Balboa St # 1097,
San Francisco, CA 94121
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Human Immunodeficiency Virus Therapeutics Market - Current Scenario and Forecast 2017 - 2025 here
News-ID: 916226 • Views: 115
More Releases from TMR Research
Factory Automation Platform as a Service Market Scope and Opportunities Analysis …
Global Factory Automation Platform as a Service Market: Snapshot Platform as a service is the term given to the collection of services and solutions that make use of cloud computing services in order to create a platform for clients and users to manage, run, and develop relevant applications while forgoing the extremely complicated task of creating and maintaining the required infrastructure. Platforms as a service, or PaaS, are commonly segregated into
HVAC Market Segmentation Detailed Study with Forecast to 2025 | Ingersoll Rand, …
Global HVAC Market: Snapshot HVAC is short for heating, ventilation, and air conditioning, and players in the global HVAC market are concerned with the development, innovation, manufacturing, and distribution of these systems and equipment. HVAC in computing is the control of the environment that an enterprise or a data center is operating in. It involves changing the ambient temperature, humidity, and other factors to better suit the optimal performance of
People Counting System Market Latest Trends and Future Growth Study by 2025 : Ke …
Global People Counting System Market: Snapshot People counting systems are devices that are used to count the number of people traversing a certain entrance or passage. In retail stores, they are usually deployed to calculate conversion rate and marketing effectiveness and are used in staff planning. In crowded places such as shopping malls and concerts, other than their conventional job of calculating footfall, they are used for crowd management and monitoring
Sensors Market Share and Growth Factors Impact Analysis 2017 - 2025 | Siemens AG …
Global Sensors Market: Snapshot The global sensors market is prophesied to record a healthy CAGR during the forecast period 2017–2025 on account of the growing application of intelligent management and monitoring in the smart systems industry. Distributed sensor networks are heavily engaged for transmitting control instructions and valuable measurement information after interconnecting the devices in networked embedded systems. In today’s era of smart technologies, vendors could take advantage of key
More Releases for HIV
Global HIV Market to 2024
The HIV market was valued at $16bn in 2015 and is forecast to expand at a CAGR of 3.7% between 2015 and 2024, culminating in 2024 global sales of $23bn.The expected arrival of new classes of therapies could result in a paradigm shift in the treatment of HIV treatment. Globally, around 35 million people are infected with HIV. Approximately 3 million people in the U.S and 2.5 million in top 5
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Infection Pipeline Analysis
The discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retrovirals in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have
Global HIV Therapeutics Market
The HIV Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral
Approaches to HIV Eradication
The various approaches to HIV eradication all address a problem, and that problem is the HIV reservoir. HIV reservoirs have been called the last hiding place for HIV within the body. The final step toward finding a cure against HIV lies in dealing with HIV reservoirs. Toulon, France, August 30, 2011 - What can be done about HIV eradication? The advancements in scientific technology and medical treatments have made significant progress